- Home
- GPRO vs GALT Comparison
GPRO vs GALT Comparison
Compare GPRO & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- GALT
- Stock Information
- Founded
- GPRO 2004
- GALT 2000
- Country
- GPRO United States
- GALT United States
- Employees
- GPRO N/A
- GALT N/A
- Industry
- GPRO Industrial Machinery/Components
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- GPRO Consumer Discretionary
- GALT Health Care
- Exchange
- GPRO Nasdaq
- GALT Nasdaq
- Market Cap
- GPRO 194.6M
- GALT 232.3M
- IPO Year
- GPRO 2014
- GALT N/A
- Fundamental
- Price
- GPRO $2.31
- GALT $4.59
- Analyst Decision
- GPRO
- GALT Strong Buy
- Analyst Count
- GPRO 0
- GALT 3
- Target Price
- GPRO N/A
- GALT $6.00
- AVG Volume (30 Days)
- GPRO 12.4M
- GALT 348.2K
- Earning Date
- GPRO 11-06-2025
- GALT 11-12-2025
- Dividend Yield
- GPRO N/A
- GALT N/A
- EPS Growth
- GPRO N/A
- GALT N/A
- EPS
- GPRO N/A
- GALT N/A
- Revenue
- GPRO $746,731,000.00
- GALT N/A
- Revenue This Year
- GPRO N/A
- GALT N/A
- Revenue Next Year
- GPRO $9.72
- GALT N/A
- P/E Ratio
- GPRO N/A
- GALT N/A
- Revenue Growth
- GPRO N/A
- GALT N/A
- 52 Week Low
- GPRO $0.40
- GALT $0.73
- 52 Week High
- GPRO $2.58
- GALT $6.55
- Technical
- Relative Strength Index (RSI)
- GPRO 72.64
- GALT 53.65
- Support Level
- GPRO $1.44
- GALT $4.21
- Resistance Level
- GPRO $2.47
- GALT $6.55
- Average True Range (ATR)
- GPRO 0.20
- GALT 0.47
- MACD
- GPRO 0.07
- GALT -0.05
- Stochastic Oscillator
- GPRO 76.92
- GALT 24.03
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.